byiShook Opinion
Aug 19, 2024 - 18:50
Novavax stock remains volatile. After hitting a two-year high in June on enthusiasm for its updated Covid vaccine, shares have pulled back. The post Novavax Stock Rocketed This Year, But Challenges Persist. Is It A Buy Or A Sell? appeared first on Investor's Business Daily.
Novavax stock remains volatile. After hitting a two-year high in June on enthusiasm for its updated Covid vaccine, shares have pulled back.
The post Novavax Stock Rocketed This Year, But Challenges Persist. Is It A Buy Or A Sell? appeared first on Investor's Business Daily.